Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses

BioTechniques

Volumn 54, Issue 6, 2013, Pages 345-348

  Desbien, Anthony L ^a   van Hoeven, Neal ^a   Reed, Steven J ^a   Casey, Allen C ^a   Laurance, John D ^a   Baldwin, Susan L ^a   Duthie, Malcolm S ^a   Reed, Steven G ^a   Carter, Darrick ^a,b  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b Protein Advances Inc   (United States)

Author keywords

Antibody; Breadth; Influenza hemagglutinin; Protein microarray; Vaccination

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A;

ACCURACY; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC VARIABILITY; HUMAN; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; NONHUMAN; PROTEIN MICROARRAY; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; FERRETS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED C57BL; PROTEIN ARRAY ANALYSIS;

MUSTELA;

EID: 84878964863     PISSN: 07366205     EISSN: 19409818     Source Type: Journal    
DOI: 10.2144/000114041     Document Type: Article

References (19)

1. Song, J.M., N. Van Rooijen, J. Bozja, R.W. Compans, and S.M. Kang. 2011. Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus. Proc. Natl. Acad. Sci. USA 108:757-761.
2. Neirynck, S., T. Deroo, X. Saelens, P. Vanlandschoot, W.M. Jou, and W. Fiers. 1999. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5:1157-1163.
3. Wei, C.J., J.C. Boyington, P.M. McTamney, W.P. Kong, M.B. Pearce, L. Xu, H. Andersen, S. Rao, et al. 2010. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060-1064.
4. Corti, D., J. Voss, S.J. Gamblin, G. Codoni, A. Macagno, D. Jarrossay, S.G. Vachieri, D. Pinna, et al. 2011. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856.
5. Russell, C.J. 2011. Stalking influenza diversity with a universal antibody. N. Engl. J. Med. 365:1541-1542.
6. Ekiert, D.C., G. Bhabha, M.A. Elsliger, R.H. Friesen, M. Jongeneelen, M. Throsby, J. Goudsmit, and I.A. Wilson. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
7. Oh, S.J., B.J. Hong, K.Y. Choi, and J.W. Park. 2006. Surface modification for DNA and protein microarrays. OMICS 10:327-343.
8. Zhou, F.X., J. Bonin, and P.F. Predki. 2004. Development of functional protein microarrays for drug discovery: progress and challenges. Comb. Chem. High Throughput Screen. 7:539-546.
9. Medina, R.A. and A. Garcia-Sastre. 2011. Influenza A viruses: new research developments. Nat. Rev. Microbiol. 9:590-603.
10. Gall, A., B. Hoffmann, T. Harder, C. Grund, D. Hoper, and M. Beer. 2009. Design and validation of a microarray for detection, hemagglutinin subtyping, and pathotyping of avian influenza viruses. J. Clin. Microbiol. 47:327-334.
11. Koopmans, M., E. de Bruin, G.J. Godeke, I. Friesema, R. van Gageldonk, M. Schipper, A. Meijer, R. van Binnendijk, et al. 2012. Profiling of humoral immune responses to influenza viruses by using protein microarray. Clin. Microbiol. Infect. 18:797-807.
12. Tan, G.S., F. Krammer, D. Eggink, A. Kongchanagul, T.M. Moran, and P. Palese. 2012. A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J. Virol. 86:6179-6188.
13. Hai, R., F. Krammer, G.S. Tan, N. Pica, D. Eggink, J. Maamary, I. Margine, R.A. Albrecht, and P. Palese. 2012. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J. Virol. 86:5774-5781.
14. Mosmann, T.R. and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
15. Coler, R.N., S.L. Baldwin, N. Shaverdian, S. Bertholet, S.J. Reed, V.S. Raman, X. Lu, J. DeVos, et al. 2010. A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS ONE 5:e13677.
16. Behzad, H., A.L. Huckriede, L. Haynes, B. Gentleman, K. Coyle, J.C. Wilschut, T.R. Kollmann, S.G. Reed, and J.E. McElhaney. 2012. GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults. J. Infect. Dis. 205:466-473.
17. Fox, C.B., S.L. Baldwin, T.S. Vedvick, E. Angov, and S.G. Reed. 2012. Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines. Clin. Vaccine Immunol. 19:1633-1640.
18. Clegg, C.H., R. Roque, N. Van Hoeven, L. Perrone, S.L. Baldwin, J.A. Rininger, R.A. Bowen, and S.G. Reed. 2012. Adjuvant solution for pandemic influenza vaccine production. Proc. Natl. Acad. Sci. USA 109:17585-17590.
19. Miura, K., A.C. Orcutt, O.V. Muratova, L.H. Miller, A. Saul, and C.A. Long. 2008. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine 26:193-200.